Intimate partner violence and receptive syringe sharing among women who inject drugs in Indonesia: A respondent-driven sampling study.

Journal: The International journal on drug policy

Volume: 63

Issue: 

Year of Publication: 2020

Affiliated Institutions:  Centre for Evidence-Based Intervention, University of Oxford, Oxford, United Kingdom. Electronic address: claudia.stoicescu@spi.ox.ac.uk. Centre for Evidence-Based Intervention, University of Oxford, Oxford, United Kingdom; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa. Centre for Evidence-Based Intervention, University of Oxford, Oxford, United Kingdom. Faculty of Public Health, University of Indonesia, Depok, Indonesia; HIV/AIDS Research Centre, Atma Jaya University, Jakarta, Indonesia. Department of Criminology, University of Indonesia, Depok, Indonesia; Faculty of Law, University of Indonesia, Depok, Indonesia.

Abstract summary 

Intimate partner violence (IPV) and HIV are overlapping public health problems that disproportionately affect women who inject drugs. Little is known about the relationship between IPV and HIV-related unsafe injecting practices among women in low- and middle-income settings. This study investigated whether IPV victimisation was associated with receptive syringe sharing among women who inject drugs in Indonesia.Respondent-driven sampling (RDS) was used to recruit 731 women aged 18+ years, injecting drugs in the preceding 12 months, and residing in Greater Jakarta or Bandung, West Java. Population estimates were derived using the RDS-II estimator. Multivariate logistic regressions assessed relationships between different forms of past-year IPV (i.e. psychological abuse, physical and/or injurious assault, forced sex) and receptive syringe sharing, controlling for city differences and sociodemographic cofactors.Overall, 21.1% of participants reported engaging in past-month receptive syringe sharing. In multivariate analyses controlling for all forms of IPV, receptive syringe sharing was significantly positively associated with experiencing psychological abuse (OR = 1.86; 95% CI = 1.06,3.24; p = 0.030), physical and/or injurious assault (OR = 1.73; 95% CI = 1.04,2.89; p = 0.034), and several covariates: injecting pharmaceuticals only (versus heroin only) (OR = 3.58; 95% CI = 1.66,7.69; p = 0.001), experiencing unstable housing and/or homelessness (OR = 2.89; 95% CI = 1.41,5.95; p = 0.004), and residing in Bandung, West Java (versus Greater Jakarta) (OR = 2.33; 95% CI = 1.40,3.90; p = 0.001).IPV is a significant risk factor for HIV-related injecting risk among women who inject drugs in Indonesia. These findings indicate the urgent need to scale up harm reduction interventions and align existing programs with IPV prevention and support services, with specific efforts targeting the needs of female injectors.

Authors & Co-authors:  Stoicescu Claudia C Cluver Lucie D LD Spreckelsen Thees F TF Mahanani Mietta M MM Ameilia Rima R

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  5
Identifiers
Doi : 10.1016/j.drugpo.2018.08.009
SSN : 1873-4758
Study Population
Women,Female
Mesh Terms
Adolescent
Other Terms
HIV;Injecting drug use;Intimate partner violence;Receptive syringe sharing;Respondent-driven sampling;Women
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
Netherlands